Thermo Fisher Scientific this week announced the release of the QuantStudio 3D Rare Mutation Analysis solution.

The new offering is a panel of wet-lab validated TaqMan SNP genotyping assays and an enhanced software tool that enables researchers to detect and quantify 40 of the most common mutations in cancer genes, including EGFR, BRAF, KRAS, PIK3CA, and JAK2, at a prevalence as low as 0.1 percent.

The primary and secondary software enhancements are also designed with specific features for analysis of low-frequency alleles on the QuantStudio 3D Digital PCR system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.